Atazanavir
CAS No. 198904-31-3
Atazanavir( BMS-232632 )
Catalog No. M13109 CAS No. 198904-31-3
A highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 60 | In Stock |
|
| 5MG | 37 | In Stock |
|
| 10MG | 53 | In Stock |
|
| 25MG | 83 | In Stock |
|
| 50MG | 114 | In Stock |
|
| 100MG | 176 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 440 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAtazanavir
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture.
-
DescriptionA highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture; shows synergistic antiviral effects in HIV-infected PBMCs; used to treat and prevent HIV/AIDS.HIV Infection Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsBMS-232632
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIVProtease
-
Research AreaInfection
-
IndicationHIV Infection
Chemical Information
-
CAS Number198904-31-3
-
Formula Weight704.8555
-
Molecular FormulaC38H52N6O7
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC
-
Chemical Name2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Robinson BS, et al. Antimicrob Agents Chemother. 2000 Aug;44(8):2093-9.
2. Gong YF, et al. Antimicrob Agents Chemother. 2000 Sep;44(9):2319-26.
3. Drusano GL, et al. J Infect Dis. 2001 Apr 1;183(7):1126-9.
molnova catalog
related products
-
BMS-955176
BMS-955176 (GSK-3532795) is a second-generation HIV-1 maturation inhibitor that exhibits potent activity (EC50=3.9±3.4 nM) against a library (n=87) of gag/pr recombinant viruses.
-
L-870810
A potent, selective inhibitor of HIV integrase (IC50=8-15 nM) with potent antiviral activity in cell culture and good pharmacokinetic properties.
-
HIV-1 Integrase Inhi...
A novel compound that disrupts the HIV-1 integrase LEDGF interaction.
Cart
sales@molnova.com